272 related articles for article (PubMed ID: 31215776)
1. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
[TBL] [Abstract][Full Text] [Related]
2. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
[TBL] [Abstract][Full Text] [Related]
3. Association Between Race/Ethnicity and Survival of Melanoma Patients in the United States Over 3 Decades: A Secondary Analysis of SEER Data.
Ward-Peterson M; Acuña JM; Alkhalifah MK; Nasiri AM; Al-Akeel ES; Alkhaldi TM; Dawari SA; Aldaham SA
Medicine (Baltimore); 2016 Apr; 95(17):e3315. PubMed ID: 27124020
[TBL] [Abstract][Full Text] [Related]
4. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
[TBL] [Abstract][Full Text] [Related]
5. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
[TBL] [Abstract][Full Text] [Related]
6. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
[TBL] [Abstract][Full Text] [Related]
7. Age as a prognostic factor in the malignant melanoma population.
Austin PF; Cruse CW; Lyman G; Schroer K; Glass F; Reintgen DS
Ann Surg Oncol; 1994 Nov; 1(6):487-94. PubMed ID: 7850555
[TBL] [Abstract][Full Text] [Related]
8. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
9. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25 720 Patients With Stage IA to IV Melanoma.
Helvind NM; Brinch-Møller Weitemeyer M; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
JAMA Dermatol; 2023 Nov; 159(11):1213-1222. PubMed ID: 37650576
[TBL] [Abstract][Full Text] [Related]
10. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
Reintgen DS; Cox C; Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
[TBL] [Abstract][Full Text] [Related]
11. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age.
Tellez A; Rueda S; Conic RZ; Powers K; Galdyn I; Mesinkovska NA; Gastman B
J Am Acad Dermatol; 2016 Apr; 74(4):731-8. PubMed ID: 26803345
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
14. Association between Lithium Use and Melanoma Risk and Mortality: A Population-Based Study.
Asgari MM; Chien AJ; Tsai AL; Fireman B; Quesenberry CP
J Invest Dermatol; 2017 Oct; 137(10):2087-2091. PubMed ID: 28629629
[TBL] [Abstract][Full Text] [Related]
15. Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: A US national and tertiary care center study.
Rachidi S; Deng Z; Sullivan DY; Lipson EJ
J Am Acad Dermatol; 2020 Oct; 83(4):1012-1020. PubMed ID: 32446825
[TBL] [Abstract][Full Text] [Related]
16. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
[TBL] [Abstract][Full Text] [Related]
17. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
18. Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011).
Cavanaugh-Hussey MW; Mu EW; Kang S; Balch CM; Wang T
Ann Surg Oncol; 2015 Jul; 22(7):2120-6. PubMed ID: 25940571
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
20. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
